| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/03/2015 | US8946175 Stabilized immunomodulatory oligonucleotides |
| 02/03/2015 | US8946168 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 02/03/2015 | US8946160 Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation |
| 02/03/2015 | US8946159 Administration of an antagonist of α5β1 for anti-angiogenesis and cancer treatment |
| 02/03/2015 | US8946158 Treatments of gastrointestinal disorders |
| 02/03/2015 | US8946124 Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols |
| 02/03/2015 | US8945929 Marker for determination of sensitivity to anti-cancer agent |
| 02/03/2015 | US8945874 Polynucleotides encoding NOTCH1 receptor antibodies |
| 02/03/2015 | US8945873 Polynucleotides encoding Notch receptor antibodies |
| 02/03/2015 | US8945636 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care |
| 02/03/2015 | US8945635 Formulations comprising extracts from primitive plant species (mosses, ferns and lichens) to treat and prevent cancers |
| 02/03/2015 | US8945621 Method for treating a patient at risk for developing an NSAID-associated ulcer |
| 02/03/2015 | US8945608 Composition and method to alleviate joint pain |
| 02/03/2015 | US8945607 Electrolyte supplement and method of use |
| 02/03/2015 | US8945604 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 02/03/2015 | US8945591 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 02/03/2015 | US8945575 Treatment of IgE-mediated disease |
| 02/03/2015 | US8945547 Notch1 receptor antibodies and methods of treatment |
| 02/03/2015 | US8945540 Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof |
| 02/03/2015 | US8945538 Bone substitute compositions, methods of preparation and clinical applications |
| 02/03/2015 | US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 02/03/2015 | US8945505 Use of arsenic compounds for treatment of pain and inflammation |
| 02/03/2015 | CA2626062C Preparation comprising iron(iii) complex compounds and redox-active substance(s) |
| 02/03/2015 | CA2608463C Compounds, compositions containing such compounds, and methods of treatment of metastatic melanoma and other cancers |
| 01/29/2015 | WO2015013591A1 Methods of treating irritable bowel syndrome |
| 01/29/2015 | WO2015013451A2 Compositions and methods for upregulating hippocampal plasticity and hippocampus-dependent learning and memory |
| 01/29/2015 | WO2015013448A1 Treatment of pancreatic cancer with a combination of a hypoxia-acti vated prodrug and a taxane |
| 01/29/2015 | WO2015012904A2 Antibody-sn-38 immunoconjugates with a cl2a linker |
| 01/29/2015 | WO2015012899A1 Pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an antiinflammatory agent |
| 01/29/2015 | WO2015012365A1 Pharmaceutical preparation |
| 01/29/2015 | WO2015012205A1 Medicine for preventing or treating hypertension |
| 01/29/2015 | WO2015011254A1 Methods and pharmaceutical compositions for the treatment of bacterial infections |
| 01/29/2015 | WO2015011245A1 Combinations comprising maba compounds and corticosteroids |
| 01/29/2015 | WO2015011244A1 SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITIES |
| 01/29/2015 | WO2015011235A1 Volasertib in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome ii |
| 01/29/2015 | WO2015011234A1 Volasertib in combination with decitabine for the treatment of acute myeloid leukemia and myelodysplastic syndrome ii |
| 01/29/2015 | WO2015011163A1 Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation. |
| 01/29/2015 | WO2015010782A1 Cancer therapy with a parvovirus combined with a bcl-2 inhibitor |
| 01/29/2015 | WO2015010450A1 Viral immunotherapy drug complex and uses thereof |
| 01/29/2015 | US20150031767 Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria |
| 01/29/2015 | US20150031753 Complexing agents for compositions containing inclusion complexes |
| 01/29/2015 | US20150031751 Compositions and methods for treatment of ovarian cancer |
| 01/29/2015 | US20150031744 Method for predicting and detecting tumor metastasis |
| 01/29/2015 | US20150031725 Compositions and methods for treating cancer |
| 01/29/2015 | US20150031723 Quinoline Compounds Which Are Anti-Angiogenic Integrin Alpha5 Beta1 Inhibitors for Use in the Treatment of Fibrosis or Fibrosis-Related Diseases |
| 01/29/2015 | US20150031722 Modulators of atp-binding cassette transporters |
| 01/29/2015 | US20150031708 Modulators of cftr |
| 01/29/2015 | US20150031706 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 01/29/2015 | US20150031705 Ophthalmic formulations including selective alpha 1 antagonists |
| 01/29/2015 | US20150031704 Methods and compositions for treating peripheral vascular disease |
| 01/29/2015 | US20150031701 Compositions and methods for preventing and treating mucositis and weight loss |
| 01/29/2015 | US20150031700 Methods of Treating Cutaneous Flushing Using Selective Alpha-2-adrenergic Receptor Agonists |
| 01/29/2015 | US20150031682 Anti-malarial agents |
| 01/29/2015 | US20150031681 Novel 1-substituted indazole derivative |
| 01/29/2015 | US20150031677 Trioxane thioacetal monomers and dimers and methods of use thereof |
| 01/29/2015 | US20150031673 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/29/2015 | US20150031671 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 01/29/2015 | US20150031670 Cyclic amides as metap-2 inhibitors |
| 01/29/2015 | US20150031669 Anticancer benzopyrazines via the inhibition of fgfr kinases |
| 01/29/2015 | US20150031656 Combination therapy for treating androgen deficiency |
| 01/29/2015 | US20150031649 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
| 01/29/2015 | US20150031648 Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/29/2015 | US20150031638 Low anticoagulant heparins |
| 01/29/2015 | US20150031637 Pharmaceutical combination comprising an ibat inhibitor and a bile acid binder |
| 01/29/2015 | US20150031634 Angiotensin peptides in treating marfan syndrome and related disorders |
| 01/29/2015 | US20150031604 Cyclic polypeptides for the treatment of heart failure |
| 01/29/2015 | US20150031603 Macrocyclic compounds for suppressing replication of hepatitis c virus |
| 01/29/2015 | US20150031601 Antimicrobial Peptide Variants and Polynucleotides Encoding Same |
| 01/29/2015 | US20150031025 Genetic products differentially expressed in tumors and use thereof |
| 01/29/2015 | US20150030704 Pyridazinone compounds and their use as daao inhibitors |
| 01/29/2015 | US20150030701 Antimicrobial compositions and methods |
| 01/29/2015 | US20150030697 Treatments for gastrointestinal disorders |
| 01/29/2015 | US20150030665 Composition and Method for Treating Connective Tissue Damage |
| 01/29/2015 | US20150030662 Generation of Brown Adipose Tissue (BAT) from Mesenchymal Cells |
| 01/29/2015 | US20150030653 Vanadium Compounds as Therapeutic Adjuncts for Cartilage Injury and Repair |
| 01/29/2015 | US20150030638 Ingenol Derivatives in the Reactivation of Latent HIV |
| 01/29/2015 | US20150030620 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 01/29/2015 | US20150030618 Novel binder-drug conjugates (adcs) and use thereof |
| 01/29/2015 | US20150030616 Novel benzodiazepine derivatives |
| 01/29/2015 | US20150030608 Method of Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 01/29/2015 | US20150030605 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 01/29/2015 | US20150030594 Bioconjugates of synthetic apelin polypeptides |
| 01/29/2015 | US20150030586 Compositions and methods for the therapy and diagnosis of cancer |
| 01/29/2015 | US20150030567 Cancer Therapy with a Parvovirus Combined with an HDAC Inhibitor |
| 01/29/2015 | US20150030564 Inhibitory agent for body cavity fluid accumulation |
| 01/29/2015 | US20150030563 Compound for the Treatment of Enteroviruses |
| 01/29/2015 | US20150030559 Compositions and methods for treating and preventing skeletal muscle deficiencies |
| 01/29/2015 | US20150030551 Benzopyran compounds as melanogenesis modifiers and uses thereof |
| 01/29/2015 | US20150030550 Composition containing at least one c7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes or nails |
| 01/29/2015 | US20150030549 Topical compositions |
| 01/29/2015 | US20150030534 Antibody cocktails for breast cancer radioimmunotherapy |
| 01/28/2015 | EP2829284A1 Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor |
| 01/28/2015 | EP2829277A1 Use of a-type proanthocyanidins in treating a mineralocorticoid receptor related disease |
| 01/28/2015 | EP2829271A2 Pharmaceutical compositions with (1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol and a further antidiabetic agent |
| 01/28/2015 | EP2828662A1 Detection and modulation of rheumatoid arthritis |
| 01/28/2015 | EP2827904A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/28/2015 | EP2827900A1 Treatment of brain cancer |
| 01/28/2015 | EP2827873A1 Method for treating gynecological diseases |
| 01/28/2015 | EP2827859A1 Combination therapy (vemrufenib and a mdm2 inhibitor) for the treatment proliferative disorders |
| 01/28/2015 | EP2827853A1 Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles |